Evidence map›Paper›PMID 35784708›Full record

ArticleFrontiers in pharmacology2022

A Worldwide Bibliometric Analysis of Tetrandrine Research in Recent Two Decades.

Guang Yang, Wenqing Xie, Yilan Ding, Weiyang Wang, Cheng Huang, Tingxiao Zhao, Yusheng Li

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Tetrandrine for Targeting Therapy Resistance in Cancer.Current topics in medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guang YangDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
Wenqing XieDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
Yilan DingXiangya School of Medicine, Central South University, Changsha, China.
Weiyang WangXiangya School of Medicine, Central South University, Changsha, China.
Cheng HuangDepartment of Orthopedics, China-Japan Friendship Hospital, Beijing, China.
Tingxiao ZhaoCenter for Plastic and Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Yusheng LiDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arthritisbibliometriccancerpharmacokineticsRStudiotetrandrineVOSviewer

Identifiers

PMID35784708
PMCPMC9240465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.